OrbiMed Genesis GP LLC — insider trades

Stock trades OrbiMed Genesis GP LLC reported on SEC Form 4 at ADRX ADARx Pharmaceuticals, Inc., ETRA Electra Therapeutics, Inc., BRVE Braveheart Bio, Inc., ELVN Enliven Therapeutics, Inc., QTTB Q32 Bio Inc..

• Sep 28, 2026: bought 950,000 shares of ADRX ADARx Pharmaceuticals, Inc. ($16.2M)
• Sep 21, 2026: bought 1,333,333 shares of ETRA Electra Therapeutics, Inc. ($20.0M)
• Aug 7, 2026: bought 1,940,000 shares of BRVE Braveheart Bio, Inc. ($34.9M)
• Jun 22, 2026: sold 860,123 shares of ELVN Enliven Therapeutics, Inc. ($39.0M)
• Jun 15, 2026: sold 281,408 shares of ELVN Enliven Therapeutics, Inc. ($12.7M)
• May 28, 2026: bought 1,875,000 shares of QTTB Q32 Bio Inc. ($15.0M)
• Apr 21, 2026: bought 2,815,315 shares of PRLD Prelude Therapeutics Inc ($12.5M)
• Apr 8, 2026: sold 104,658 shares of ACET Adicet Bio, Inc. ($675K)
• Oct 8, 2025: bought 5,000,000 shares of ACET Adicet Bio, Inc. ($5.00M)
• Aug 25, 2025: bought 6,306,127 shares of STTK Shattuck Labs, Inc. ($5.49M)